← Back to headlines
RBC Capital raises price target for Moderna (MRNA)
RBC Capital has increased its price target for Moderna (MRNA), signaling a positive outlook for the pharmaceutical company's stock.
9 Jul, 10:41 — 9 Jul, 10:41
Sources
Showing 1 of 1 sources
Related Stories
Amazon's First Customer Receipt Goes Viral, Bezos and Musk React
just now
Former Budget Secretary Amenah Pangandaman Appointed Head of Amanah Islamic Bank
just now
Ebonyi CSOs threaten legal action against EEDC over alleged overbilling, disconnections
12m ago
NIMASA urged to use 3% levy for indigenous operators' loans
19m ago